Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.

Chay WY, Chew SH, Ong WS, Busmanis I, Li X, Thung S, Ngo L, Lim SL, Lim YK, Chia YN, Koh E, Pang C, Soh LT, Wang J, Ho TH, Tay SK, Lim-Tan SK, Lim KH, Chia JW, Goh LK.

PLoS One. 2013 Apr 19;8(4):e61565. doi: 10.1371/journal.pone.0061565.

2.

Mucinous ovarian cancer.

Harrison ML, Jameson C, Gore ME.

Int J Gynecol Cancer. 2008 Mar-Apr;18(2):209-14. Review.

PMID:
17624989
3.

Unmasking the complexities of mucinous ovarian carcinoma.

Frumovitz M, Schmeler KM, Malpica A, Sood AK, Gershenson DM.

Gynecol Oncol. 2010 Jun;117(3):491-6. doi: 10.1016/j.ygyno.2010.02.010. Review.

4.

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.

Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A; Gynecologic Cancer InterGroup..

Int J Gynecol Cancer. 2010 Aug;20(6):945-52. doi: 10.1111/IGC.0b013e3181dd0110. Review.

PMID:
20683400

Supplemental Content

Support Center